Skip to content

All recalls FDA

FDADrugsRecalled Status: Closed by the agency

Cardinal Healthcare recalls Jardiance (empagliflozin tablets)

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Products
  • Jardiance (empagliflozin tablets)
Where it was sold

Nationwide USA

Nationwide

Units affected
1 unit
About this recall
Jardiance (empagliflozin tablets), 25 mg, 30 tablets (3 blister cards with 10 tablets each), Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877. NDC: 0597-0153-37